If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,446.60    1.40 (0.10%)
Bid:
1,446.60
Ask:
1,446.80
Spread: 0.20 (0.014%)
Market Cap: £248.07b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Transaction in Own Shares

20 Mar 2024 17:51

RNS Number : 6793H
HSBC Holdings PLC
20 March 2024
 

HSBC HOLDINGS PLC

20 March 2024

Transaction in own shares

 

HSBC Holdings plc ("HSBC" or the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of US$0.50 from Merrill Lynch International ("Merrill Lynch ") as part of its buy-back announced on 22 February 2024.

UK Venues

Date of purchase:

20 March 2024

Number of ordinary shares of US$0.50 each purchased:

2,485,084 

Highest price paid per share:

£6.0800 

Lowest price paid per share:

£5.9900 

Volume weighted average price paid per share:

£6.0324 

 

All repurchases on the London Stock Exchange, Cboe Europe Limited (through the BXE and CXE order books) and/or Turquoise ("UK Venues") are implemented as "on Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and as "market purchases" for the purposes of the Companies Act 2006.

Hong Kong Stock Exchange

Date of purchase:

20 March 2024

Number of ordinary shares of US$0.50 each purchased:

1,839,600

Highest price paid per share:

HK$59.8000

Lowest price paid per share:

HK$59.6000

Volume weighted average price paid per share:

HK$59.6947

All repurchases on The Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange") are "off market" for the purposes of the Companies Act 2006 but are transactions which occur "on Exchange" for the purposes of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and which constitute an "on-market share buy-back" for the purposes of the Codes on Takeovers and Mergers and Share Buy-backs.

Since the commencement of the buy-back announced on 22 February 2024, the Company has repurchased 113,242,775 ordinary shares for a total consideration of approximately US$862.9m.

Following the cancellation of the shares repurchased on the UK Venues, the Company's issued ordinary share capital will consist of 18,993,436,083 ordinary shares with voting rights. There are no ordinary shares held in treasury. Cancellation of the shares repurchased on the Hong Kong Stock Exchange takes longer than those repurchased on the UK Venues and a further announcement of total voting rights will be made once those shares have been cancelled.

The above figure of 18,993,436,083 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades made by Merrill Lynch on behalf of the Company is available via the link below.

http://www.rns-pdf.londonstockexchange.com/rns/6793H_1-2024-3-20.pdf

This announcement will also be available on HSBC's website at www.hsbc.com/sea

Enquiries to:

Lee DavisCorporate Governance & Secretariat

+44 (0) 207 991 3048

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKKBNOBKDDNB
Date   Source Headline
13th Jan 202610:00 amRNSOverseas Regulatory Announcement - Grant of Awards
8th Jan 202610:55 amRNSPrivatisation of HangSengBank- Results of Meetings
5th Jan 20263:00 pmRNSBlock listing Interim Review
30th Dec 20259:00 amRNSPost Stabilisation Notice
30th Dec 20259:00 amRNSPost Stabilisation Notice
29th Dec 20253:00 pmRNSTotal Voting Rights
29th Dec 20253:00 pmRNSTotal Voting Rights
23rd Dec 20257:00 amRNSBoard Changes
22nd Dec 20253:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:52 pmRNSHolding(s) in Company
18th Dec 20255:52 pmRNSHolding(s) in Company
18th Dec 20258:30 amRNSChange in Joint Company Secretary
17th Dec 20252:45 pmRNSPrivatisation of HangSengBank-Scheme Document Supp
15th Dec 20257:00 amRNSPrivatisation of Hang Seng Bank - Scheme Document
8th Dec 20251:00 pmRNSThird Interim Dividend for 2025 - Exchange Rate
3rd Dec 20257:00 amRNSGroup Chair Succession
2nd Dec 20257:45 amRNSStatement on BoE 2025 BCST results
1st Dec 20254:15 pmRNSIssuance of senior unsecured notes
28th Nov 20253:01 pmRNSTotal Voting Rights
28th Nov 20253:00 pmRNSDirector/PDMR Shareholding
28th Nov 20259:24 amRNSHolding(s) in Company
27th Nov 20258:30 amRNSGrant of Relevant Consents under HK Takeovers Code
27th Nov 20258:30 amRNSMonthly update on privatisation of Hang Seng Bank
24th Nov 20259:30 amRNSPre Stabilisation Notice
12th Nov 20253:00 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSChanges to Board and Committee Composition
6th Nov 20254:15 pmRNSIssuance of senior unsecured notes
6th Nov 20253:00 pmRNSTotal Voting Rights
5th Nov 202512:00 pmRNSOverseas Regulatory Announcement - Grant of Awards
4th Nov 20253:00 pmRNSDirector/PDMR Shareholding
31st Oct 20253:00 pmRNSTotal Voting Rights
30th Oct 20253:00 pmRNSDirector/PDMR Shareholding
30th Oct 20258:30 amRNSUpdate on Timeline for Despatch of Scheme Document
29th Oct 20255:30 pmRNSPublication of base prospectus supplement
28th Oct 20253:00 pmRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNS3Q 2025 Earnings Release Zoom Meeting
28th Oct 20257:00 amRNSHSBC Holdings plc earnings release 3Q25
27th Oct 20257:00 amRNSHerald Fund litigation relating to Madoff fraud
24th Oct 20254:00 pmRNSTransaction in Own Shares & Conclusion of Buy-back
21st Oct 20254:29 pmRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares - Replacement
17th Oct 20255:42 pmRNSTransaction in Own Shares
16th Oct 20256:04 pmRNSTransaction in Own Shares
16th Oct 20259:30 amRNSOverseas Regulatory Announcement - Board Meeting
15th Oct 20255:35 pmRNSTransaction in Own Shares
14th Oct 20255:35 pmRNSTransaction in Own Shares
13th Oct 20256:02 pmRNSTransaction in Own Shares
10th Oct 20255:40 pmRNSTransaction in Own Shares
10th Oct 202510:00 amRNSOverseas Regulatory Announcement - Grant of Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.